Skip to content

Can a 70 year old get a heart transplant?

4 min read

According to recent studies, the number of heart transplants performed on adults aged 65 and older is on the rise, proving that chronological age is no longer the sole determining factor for eligibility. This shift challenges outdated perceptions and raises the crucial question: can a 70 year old get a heart transplant?

Quick Summary

The decision for a heart transplant in a 70-year-old is based on a holistic assessment of overall health and biological age, not just chronological age, with outcomes for carefully selected older adults showing excellent results comparable to younger recipients. The process involves comprehensive medical, psychological, and social evaluations by a multidisciplinary team to ensure the patient can withstand the surgery and adhere to rigorous post-transplant care.

Key Points

  • Age is Not an Automatic Bar: A patient's biological and overall health are more important than chronological age when determining heart transplant eligibility.

  • Thorough Evaluation: A multidisciplinary team conducts comprehensive medical, psychological, and social evaluations to select appropriate candidates, especially those over 70.

  • Similar Success Rates: Studies indicate that carefully selected patients aged 70 and older can achieve one- and five-year survival rates comparable to younger recipients.

  • Increased Risk Profile: Older recipients may face a higher risk of infection and certain malignancies due to long-term immunosuppression.

  • Lifelong Commitment: Successful outcomes depend on strict adherence to a lifelong regimen of medication, frequent monitoring, and lifestyle changes.

  • Alternative Therapies: For those not suitable for transplant, options like ventricular assist devices (LVADs) or palliative care are available.

  • Prioritizing Physiologic Health: The modern approach emphasizes a candidate's overall functional status and integrity of other organ systems over a fixed age limit.

In This Article

No, age is not an absolute barrier

While historical standards once suggested upper age limits, modern medicine has increasingly focused on a patient's overall health and physiological age rather than their chronological age. The International Society for Heart and Lung Transplantation (ISHLT) provides guidelines that recommend considering candidates up to age 70 for transplantation, and carefully selected patients over 70 can also be considered. This practice is driven by improving surgical techniques and post-transplant management, which have led to better outcomes for older recipients.

The evaluation for a heart transplant is an intensive, multi-faceted process designed to determine if the patient is medically and psychosocially equipped for the procedure and the intensive care required afterward. Advanced age introduces unique considerations, but is not, in itself, a disqualifying factor.

The comprehensive evaluation process for older adults

Before a patient is placed on the national waiting list, a multidisciplinary transplant team will conduct a thorough evaluation. This process is particularly rigorous for older adults, as the presence of other health conditions (comorbidities) becomes more relevant with age.

Medical assessment

  • Cardiopulmonary exercise testing (CPET): Measures how the heart and lungs respond to exercise, providing insight into the severity of heart failure.
  • Right heart catheterization: Assesses pressures within the heart and lungs. High pulmonary pressure can be a contraindication to transplant.
  • Organ function tests: A full panel of blood and urine tests evaluate the function of the kidneys, liver, and other vital organs, which must be healthy enough to withstand surgery and immunosuppression.
  • Cancer screening: Older adults have a higher risk of malignancy, and active cancer is an absolute contraindication for a heart transplant due to the immunosuppressive therapy.

Psychosocial and support evaluation

Transplantation is a life-altering event requiring significant emotional resilience and a robust support network. The psychosocial evaluation for older adults is critical.

  • Mental and emotional stability: Assessing the patient's ability to cope with the stress of transplantation and the recovery process.
  • Adherence to treatment: The team must be confident that the patient will consistently follow a complex medical regimen for life.
  • Caregiver support: A dedicated caregiver is essential, especially during the intensive recovery period immediately following surgery.
  • Financial resources: A financial coordinator will discuss costs and insurance coverage, which can be significant.

Potential risks and success rates for older recipients

Studies have shown that outcomes for carefully selected older heart transplant recipients are quite good, and in many cases, comparable to those of younger patients. However, some differences and increased risks exist, which the evaluation process is designed to address.

  • Higher risk of infection and malignancy: The immunosuppressive medications required to prevent organ rejection increase the risk of infection and certain cancers. Older adults, who may already have a weaker immune system (immunosenescence), are monitored particularly closely.
  • Comparable survival rates: While some studies show slightly lower survival rates for older adults in the first year, outcomes can be similar to younger cohorts at the five-year mark. The initial difference is often attributed to the selection of healthier older patients, who may receive higher-risk donor organs that are not offered to younger recipients.
  • Immunological advantages: Interestingly, older recipients can sometimes have a reduced risk of organ rejection, potentially due to age-related changes in the immune system.

Comparison: Heart Transplant vs. Alternative Therapies

Feature Heart Transplant (Older Adult) Ventricular Assist Device (LVAD) Destination Therapy Palliative Care / Medical Management
Surgical Risk High, requires open-heart surgery. High, involves open-heart surgery. Minimal or no surgical risk.
Life Expectancy Significant extension with good quality of life possible. Varies, but offers long-term support for those ineligible for transplant. Focused on managing symptoms and improving quality of life, not extending life.
Quality of Life Drastically improved, can return to active lifestyle. Good quality of life for many, but involves managing a mechanical device. Maximizing comfort and symptom relief.
Immunosuppression Required for life to prevent rejection. Not required. Not required.
Follow-up Care Intensive, frequent monitoring required for life. Requires ongoing management of the device and battery pack. Less intensive, focused on symptom control.

Life after a heart transplant at 70+

For older adults who undergo a heart transplant, the path to recovery and long-term health is structured and demanding. Post-operative care involves a long-term commitment to a strict regimen.

  1. Medication adherence: The most critical aspect of post-transplant care is taking immunosuppressive medications exactly as prescribed for the rest of their lives.
  2. Frequent monitoring: Regular biopsies, blood tests, and check-ups are necessary to monitor for signs of rejection or infection.
  3. Cardiac rehabilitation: An exercise program is essential to regain strength and stamina lost during the pre-transplant illness and surgery.
  4. Diet and lifestyle modifications: A heart-healthy diet is crucial, along with avoiding smoking and excessive alcohol use.
  5. Support system: The long-term support of caregivers is vital for successful recovery and management.

For more detailed information on heart health, consider visiting the American Heart Association.

Conclusion

In conclusion, advanced age, including being 70 years old, is not an automatic disqualification for receiving a heart transplant. The focus has rightly shifted from a patient's chronological age to their overall physiological fitness and ability to withstand the rigors of the procedure and post-transplant care. The comprehensive, multidisciplinary evaluation process ensures that only the most suitable candidates are selected, maximizing the chances of a successful outcome and improved quality of life. For older adults with advanced heart failure, a heart transplant can be a viable and life-extending option, provided a careful selection process is followed, and the patient is committed to the demands of long-term care.

Frequently Asked Questions

While there is no strict upper age limit, eligibility is determined by a patient's overall health, not their age alone. The International Society for Heart and Lung Transplantation (ISHLT) suggests considering patients up to age 70 and, with careful selection, those over 70 as well.

The evaluation is a rigorous, multi-day process involving numerous medical tests, psychosocial assessments, and consultations with a multidisciplinary team. It aims to determine if the patient is healthy enough for the surgery, has adequate social support, and can adhere to the demanding post-transplant care regimen.

Recent studies suggest that survival rates for carefully selected heart transplant recipients aged 70 and older are comparable to those of younger patients, particularly in the mid-term (e.g., five-year).

Older recipients face a higher risk of infections and certain types of malignancy due to the necessary long-term immunosuppressive medication. Their risk of organ rejection may be lower, but this varies.

For patients not deemed suitable for a transplant, alternative therapies are considered. These may include a Left Ventricular Assist Device (LVAD) for long-term support or a shift to palliative care focused on symptom management and quality of life.

A robust and dedicated caregiver support system is absolutely crucial. A caregiver assists with medication management, appointments, and overall care, especially in the first few months after surgery.

Recovery can vary, but most patients require a 7-14 day hospital stay, followed by intensive outpatient rehabilitation. The first year requires very frequent monitoring and check-ups to manage the new organ.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.